본 실험은 마우스 초기배의 체외배양에 있어서 배양액 첨가제로서 기초배양액에 RPMI 1640 아미노산, MEM 비타민 및 사람의 성숙 난포액(hFF)을 각각 5가지의 농도로 구분하여 첨가했을 경우, 각 첨가제가 배 발달에 미치는 영향과 각 첨가제의 적정 첨가농도를 검토하고자 수행하였다. 그 결과를 요약하면 다음과 같다. 1. 배양액에 RPMI 1640 아미노산을 무첨가, 0.25%, 0.5%, 1% 및 2%의 농도로 첨가했을 때 배반포 발생율은 각각 35.5%, 54.5%, 65.4%, 48.2% 및 57.4%로 나타났으며, 0.5% 첨가구에서 유의하게 높았다. 2. 배양액에 MEM 비타민을 무첨가, 0.25%, 0.5%, 1% 및 2%의 농도로 첨가했을 때 배반포 발생율은 각각 12.8%, 22.4%, 31.1%, 21.9% 및 19.0%로 나타났으며, 0.5% 첨가구에서 유의하게 높았다. 3. 배양액에 hFF를 무첨가 2.5%, 5%, 10% 및 20%의 농도로 첨가했을 때 배반포 발생율은 각각 20.6%, 20.9%, 21.2%, 18.9% 및 29.4%로 나타났으며, 20% 첨가구에서 가장 높았다. 【These experiments were conducted to investigate the effects and optimal concentrations of RPMI 1640 amino acids, MEM vitamins and human follicular fluid(hFF) as additives in the medium for in vitro culture of mouse embryos. The results obtained were as follows. 1. The development rates of blastocyst stage were 54.5%, 65.4%, 48.2%, 57.4% and 35.5% when the medium was added to 0.25%, 0.5%, 1%, 2% of RPMI 1640 amino acid and control, respectively. The addition of 0.5% RPMI 1640 amino acid was the best concentration. 2. The development rates of blastocyst stage were 22.4%, 31.3%, 21.9%, 19.0% adn 12.8% when the medium was added to 0.25%, 0.5%, 1%, 2% of MEM vitamin and control, respectively. The addition of 0.5% MEM vitamin was the best concentration. 3. The development rates of blastocyst stage were 20.9%, 21.9%, 18.9%, 29.4% and 20.6% when the medium was added to 2.5%, 5%, 10%, 20% of hFF and control, respectively.】
This research was conducted to obtain the basic information on the cell phenomenon occuring during early development vitro of mouse embryos. Early embryos were recovered at 3h post-hGG injection(hph). Various chemicals (EDTA, EGTA, DTPA, MA and PRA) were tested to examine the effects of them on the overcoming the 2-cell phenomenon. One hundreds M of the chelating agents were added to the M16 medium containing embryos. The treated embryos were worked and transferd to fresh M16 medium after 1, 3, 6 and 12h of treatment. Development was examined at 58 and l2Oph injection, respectively. 44.7~68.9% of the treated embryos developed to 4-cell stages at 58hph. Only 17.6~60.3% of the embyos developed upto blastocyst at l20hph. Whereas control embryos showed slightly lower development M16 medium alone (38.9~42.4%, 4-cell and 3.8~65.5%, blastocyst). Three mitogenic agents were tested. 51.6~63.8% and 43.4~48.1% of embryos developed up to 2-cell and blastocyst stage, respectively when treated 5 g PHA-M Imi for 5 min, 1, 3 and 6h subsequently cultured fresh M16 medium. Control embryos only showed 38.8% for 4cell and 5.9% fo blastocyst at 58 and l2Ohph, respectively. 100M PMA was also beneficial for the 2-cell block. Showing better development them that of control (42.4 vs 57.9~59.4% 4cell and 5.9 vs 25.0~55.6% blastocyst, respectively. However 1M butyric acid was toxic to early embryos, thus arresting further development. These result indicate that either chelating or mitogenic agents could be used to overcome the in vitro 2-cell block occuring during early development vitro of ICR embryosCR embryos
【This research was conducted to observe developmental capacity of the early embryos aggrigated to phytohemagglutinin-M(PHA-M) in the culture of mouse embryos in vitro. The results showed that the development of blastocyst increased to 2-celT > $\times$ 4-cell : 92.5% and 8-cell $\times$ 8-cell : 97.3% in the aggrigated embryos of ICR mouse, and 2-cell $\times$ 2-cell : 90.0%, 4-cell $\times$ 4-cell : 93.9% and 8-cell $\times$ 8-cell : 100% in the aggrigated embryos of two different strains (ICR $\times$ CBA/J mouse). (Key words : aggrigated embryos, in vitro 2-cell block, phytohemagglutinin-M, blastocyst)】
A total of 471 follicular oocytes obtained from the immature goats treated with PMSG alone, with PMSG and hCG or without gonadotropins was used in this experiments to study the maturation of follicular oocytes in vitro and the effects of the presence of cumulus cells on their maturation. There was no difference in the proportion of oocytes at the germinal vesicle stage between oocytes having intact cumulus cells and those without cumulus cells, when they were fixed and examined immediately after collection. The oocytes with dispersed cumulus cells obtained from goats treated with PMSG and hCG were almost at the 2nd metaphase stage at the time of collection, and they could be used for in vitro fertilization immediately after collection. After cultivation for 25-35 h, the overall maturation rate to the 2nd metaphase was 62% and 57% in the oocytes with intact cumulus cells from goat treated with PMSG alone and without gonadotropins, and it was 67% in those from goats treated with PMSG and hCG after cultivation for 25-30 h. The results of this experiment suggest that the follicular oocytes with intact cumulus cells could be normally matured in vitro, while the oocytes without cumulus cells could not.